122 related articles for article (PubMed ID: 36611940)
1. Nalfurafine Hydrochloride, a κ-Opioid Receptor Agonist, Induces Melanophagy via PKA Inhibition in B16F1 Cells.
Lee HJ; Kim SH; Kim YH; Kim SH; Oh GS; Bae JE; Kim JB; Park NY; Park K; Yeom E; Jeong K; Kim P; Jo DS; Cho DH
Cells; 2022 Dec; 12(1):. PubMed ID: 36611940
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid inhibits pigmentation by increasing melanosomal autophagy in B16F1 cells.
Park HJ; Jo DS; Choi DS; Bae JE; Park NY; Kim JB; Chang JH; Shin JJ; Cho DH
Biochem Biophys Res Commun; 2020 Oct; 531(2):209-214. PubMed ID: 32792197
[TBL] [Abstract][Full Text] [Related]
3. Melasolv induces melanosome autophagy to inhibit pigmentation in B16F1 cells.
Park HJ; Jo DS; Choi H; Bae JE; Park NY; Kim JB; Choi JY; Kim YH; Oh GS; Chang JH; Kim HJ; Cho DH
PLoS One; 2020; 15(9):e0239019. PubMed ID: 32941497
[TBL] [Abstract][Full Text] [Related]
4. Autophagy mediates anti-melanogenic activity of 3'-ODI in B16F1 melanoma cells.
Kim ES; Shin JH; Seok SH; Kim JB; Chang H; Park SJ; Jo YK; Choi ES; Park JS; Yeom MH; Lim CS; Cho DH
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):165-70. PubMed ID: 24269817
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation.
Schwahn DJ; Xu W; Herrin AB; Bales ES; Medrano EE
Pigment Cell Res; 2001 Feb; 14(1):32-9. PubMed ID: 11277492
[TBL] [Abstract][Full Text] [Related]
6. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
7. Anti-melanogenic activity of schaftoside in Rhizoma Arisaematis by increasing autophagy in B16F1 cells.
Kim PS; Shin JH; Jo DS; Shin DW; Choi DH; Kim WJ; Park K; Kim JK; Joo CG; Lee JS; Choi Y; Shin YW; Shin JJ; Jeon HB; Seo JH; Cho DH
Biochem Biophys Res Commun; 2018 Sep; 503(1):309-315. PubMed ID: 29890139
[TBL] [Abstract][Full Text] [Related]
8. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients.
Nakao K; Mochizuki H
Drugs Today (Barc); 2009 May; 45(5):323-9. PubMed ID: 19584962
[TBL] [Abstract][Full Text] [Related]
9. Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys.
Nakao K; Hirakata M; Miyamoto Y; Kainoh M; Wakasa Y; Yanagita T
J Pharmacol Sci; 2016 Jan; 130(1):8-14. PubMed ID: 26786553
[TBL] [Abstract][Full Text] [Related]
10. Salicylic acid in ginseng root alleviates skin hyperpigmentation disorders by inhibiting melanogenesis and melanosome transport.
Liu J; Jiang R; Zhou J; Xu X; Sun Z; Li J; Chen X; Li Z; Yan X; Zhao D; Zheng Z; Sun L
Eur J Pharmacol; 2021 Nov; 910():174458. PubMed ID: 34480884
[TBL] [Abstract][Full Text] [Related]
11. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways.
Yoon SW; Goh SH; Chun JS; Cho EW; Lee MK; Kim KL; Kim JJ; Kim CJ; Poo H
J Biol Chem; 2003 Aug; 278(35):32914-20. PubMed ID: 12816950
[TBL] [Abstract][Full Text] [Related]
12. Essential structure of the κ opioid receptor agonist nalfurafine for binding to the κ receptor.
Nagase H; Fujii H
Curr Pharm Des; 2013; 19(42):7400-14. PubMed ID: 23448474
[TBL] [Abstract][Full Text] [Related]
13. Depigmentation of α-melanocyte-stimulating hormone-treated melanoma cells by β-mangostin is mediated by selective autophagy.
Lee KW; Ryu HW; Oh SS; Park S; Madhi H; Yoo J; Park KH; Kim KD
Exp Dermatol; 2017 Jul; 26(7):585-591. PubMed ID: 27714857
[TBL] [Abstract][Full Text] [Related]
14. {alpha}MSH and Cyclic AMP elevating agents control melanosome pH through a protein kinase A-independent mechanism.
Cheli Y; Luciani F; Khaled M; Beuret L; Bille K; Gounon P; Ortonne JP; Bertolotto C; Ballotti R
J Biol Chem; 2009 Jul; 284(28):18699-706. PubMed ID: 19389708
[TBL] [Abstract][Full Text] [Related]
15. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.
Ao Y; Park HY; Olaizola-Horn S; Gilchrest BA
Exp Cell Res; 1998 Oct; 244(1):117-24. PubMed ID: 9770355
[TBL] [Abstract][Full Text] [Related]
16. Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes.
Kadekaro AL; Chen J; Yang J; Chen S; Jameson J; Swope VB; Cheng T; Kadakia M; Abdel-Malek Z
Mol Cancer Res; 2012 Jun; 10(6):778-86. PubMed ID: 22622028
[TBL] [Abstract][Full Text] [Related]
17. Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein.
Ando A; Sasago S; Ohzone Y; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):549-58. PubMed ID: 26058994
[TBL] [Abstract][Full Text] [Related]
18. Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action.
Mandrika I; Muceniece R; Wikberg JE
Biochem Pharmacol; 2001 Mar; 61(5):613-21. PubMed ID: 11239505
[TBL] [Abstract][Full Text] [Related]
19. The in vitro and in vivo depigmenting activity of pterostilbene through induction of autophagy in melanocytes and inhibition of UVA-irradiated α-MSH in keratinocytes via Nrf2-mediated antioxidant pathways.
Hseu YC; Vudhya Gowrisankar Y; Wang LW; Zhang YZ; Chen XZ; Huang PJ; Yen HR; Yang HL
Redox Biol; 2021 Aug; 44():102007. PubMed ID: 34049220
[TBL] [Abstract][Full Text] [Related]
20. Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice.
Zhou Y; Kreek MJ
Alcohol Clin Exp Res; 2019 Jun; 43(6):1077-1090. PubMed ID: 30908671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
